Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cilia- and flagella-associated protein 184 (CFAP184) is a coiled-coil domain-containing structural protein that plays a critical role in the assembly and proper function of cilia and flagella. It participates in regulating ciliary beating by connecting the radial spoke 3 (RS3) to the inner dynein arm and the nexin-dynein regulatory complex, contributing to the structural integrity of ciliary axonemes. Mutations in CFAP184 have been linked to cone-rod dystrophy (CRD18) and primary ciliary dyskinesia, implicating CFAP184 in the pathogenesis of ciliopathies and certain inherited retinal disorders. There is currently no evidence that CFAP184 serves as a therapeutic target or interacts directly with approved drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cilia- and flagella-associated protein 184 (CFAP184).